Adicet Bio, Inc. Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
Adicet Bio, Inc. (ACET) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $3.71 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $3.71M.
- 2026-03-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $3.71M.
- 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $4.01M.
- 2025-09-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $1.06M.
| Period end | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months |
|---|---|
| 2026-06-30 | $3.71M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.71M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.01M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.11M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $3.39M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $4.66M 10-K · filed 2025-03-06 |
| 2024-09-30 | $1.27M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.53M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.77M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $5.01M 10-K · filed 2024-03-19 |
| 2022-12-31 | $4.25M 10-K · filed 2023-03-15 |
| 2021-12-31 | $2.93M 10-K · filed 2022-03-15 |
| 2020-12-31 | $2.50M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |